Avivo Biomedical Inc
$10,994,000.00 CAD
- Program
- Life Sciences Fund Contributions
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- January 1, 2026 – March 31, 2030
- Reference
- ic:033-2025-2026-Q4-515746
Published purpose
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
In plain English AI-generated
Funding to Avivo Biomedical Inc to scale up production, complete preclinical studies, and launch first-in-human clinical trials for a universal blood and organ platform.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.